Comments
Laurus Labs Ltd has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for its Unit 1and 3, located at Parawada near Visakhapatnam, Andhra Pradesh.
With this, the units had successfully cleared the inspection conducted by the US regulator in August 2017, the Hyderabad-based company said in a release issued here on Tuesday.
Laurus Lab’s scrip ended flat at Rs 524.80 on the Bombay Stock Exchange on Tuesday.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.